Org Partners LLC Tg Therapeutics, Inc. Transaction History

Org Partners LLC

$644 Million
Q2 2024

A detailed history of Org Partners LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Org Partners LLC holds 50 shares of TGTX stock, worth $1,254. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$1,254

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Jul 16, 2024	BUY	$13.32 - $19.19 $666 - $959	50 New	50 $0
Q2 2023 Jul 25, 2023	BUY	$15.48 - $35.0 $774 - $1,750	50 New	50 $1 Million

Others Institutions Holding TGTX

# of Institutions

287

Shares Held

91.8M

Call Options Held

1.9M

Put Options Held

1.45M

Vanguard Group Inc Valley Forge, PA

13.7M
Shares

$343 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$286 Million
0.0% of portfolio
State Street Corp Boston, MA

6.7M
Shares

$168 Million
0.01% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.65M
Shares

$91.4 Million
6.57% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.24M
Shares

$81.3 Million
0.07% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.64B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Org Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Org Partners LLC with notifications on news.

Account